• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[特发性扩张型心肌病患者的脂肪酸代谢:特征及预后意义]

[Fatty acid metabolism in patients with idiopathic dilated cardiomyopathy: characteristics and prognostic implications].

作者信息

Narita M, Kurihara T

机构信息

Department of Internal Medicine, Sumitomo Hospital, Osaka.

出版信息

J Cardiol. 1995 May;25(5):223-31.

PMID:7776191
Abstract

The characteristics of myocardial fatty acid metabolism in patients with idiopathic dilated cardiomyopathy (DCM) were investigated by myocardial imaging with beta-methyl-p-[123I]iodophenyl-pentadecanoic acid (BMIPP) in 16 patients with DCM, 8 patients with hypertensive heart failure (HHF), and 11 normal subjects. Rest myocardial imaging with BMIPP and 201Tl was performed on another day. The index of myocardial BMIPP uptake, or uptake ratio, was calculated from the percentage uptakes of BMIPP and 201Tl. The index of inhomogeneity of intramyocardial isotope distribution was calculated as the coefficient of variation of BMIPP and 201Tl. The uptake ratio was significantly lower in DCM and HHF patients than in normal subjects (p < 0.01). Uptake ratio correlated well with fractional shortening (r = 0.76, p < 0.01), and left ventricular ejection fraction (r = 0.58, p < 0.01). Although uptake ratio was not different between DCM and HHF patients, defects in BMIPP imaging appeared more frequently in DCM (69%) than in HHF (38%) patients. Furthermore, the extent of the defect in BMIPP imaging in DCM patients was larger than that in 201Tl imaging (p < 0.05), but in HHF patients the extent of the defects in both methods was similar. The coefficient of variation of BMIPP in DCM patients was greater than those in HHF patients and in normal subjects, but those of 201Tl were not different between the three groups. The coefficient of variation of BMIPP in DCM patients correlated well with serum norepinephrine level (r = 0.57, p < 0.01) and atrial natriuretic peptide (r = 0.77, p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

采用β-甲基-p-[123I]碘苯基十五烷酸(BMIPP)心肌显像技术,对16例特发性扩张型心肌病(DCM)患者、8例高血压性心力衰竭(HHF)患者及11名正常受试者的心肌脂肪酸代谢特征进行了研究。另一天进行了静息状态下的BMIPP和201Tl心肌显像。心肌BMIPP摄取指数(即摄取率)由BMIPP和201Tl的摄取百分比计算得出。心肌内同位素分布不均匀指数通过BMIPP和201Tl的变异系数计算。DCM和HHF患者的摄取率显著低于正常受试者(p<0.01)。摄取率与缩短分数(r=0.76,p<0.01)及左心室射血分数(r=0.58,p<0.01)密切相关。虽然DCM和HHF患者的摄取率无差异,但BMIPP显像缺损在DCM患者中(69%)比HHF患者(38%)更常见。此外,DCM患者BMIPP显像的缺损范围大于201Tl显像(p<0.05),但HHF患者两种方法的缺损范围相似。DCM患者BMIPP的变异系数大于HHF患者和正常受试者,但201Tl的变异系数在三组间无差异。DCM患者BMIPP的变异系数与血清去甲肾上腺素水平(r=0.57,p<0.01)及心钠素(r=0.77,p<0.01)密切相关。(摘要截断于250字)

相似文献

1
[Fatty acid metabolism in patients with idiopathic dilated cardiomyopathy: characteristics and prognostic implications].[特发性扩张型心肌病患者的脂肪酸代谢:特征及预后意义]
J Cardiol. 1995 May;25(5):223-31.
2
[Successive myocardial fatty acid metabolic imaging in patients with dilated cardiomyopathy: usefulness as a prognostic indicator].
Kaku Igaku. 2000 Jul;37(4):303-10.
3
Prediction of cardiac events in patients with dilated cardiomyopathy using 123I-BMIPP and 201Tl myocardial scintigraphy.使用¹²³I - BMIPP和²⁰¹Tl心肌闪烁显像术预测扩张型心肌病患者的心脏事件
Ann Nucl Med. 2007 Sep;21(7):399-404. doi: 10.1007/s12149-007-0045-8. Epub 2007 Sep 25.
4
[Prognostic value of myocardial 123I-BMIPP imaging in patients with congestive heart failure without coronary artery disease].[心肌123I-BMIPP显像对无冠心病的充血性心力衰竭患者的预后价值]
Kaku Igaku. 1998 Apr;35(4):229-37.
5
Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT.心肌病中心肌脂肪酸代谢与左心室功能及灌注的比较:通过¹²³I - BMIPP单光子发射计算机断层显像及⁹⁹ᵐTc - 替曲膦心电图门控单光子发射计算机断层显像进行研究
Ann Nucl Med. 2003 Oct;17(7):541-8. doi: 10.1007/BF03006666.
6
Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.使用123I BMIPP SPECT评估特发性扩张型心肌病患者心肌脂肪酸代谢异常:与临床病理结果及临床病程的相关性
Heart. 1999 Feb;81(2):153-9. doi: 10.1136/hrt.81.2.153.
7
[Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].肥厚型心肌病与高血压性心肌肥厚之间的心肌脂肪酸代谢是否存在差异?
Kaku Igaku. 1994 Dec;31(12):1465-76.
8
[Phase 3 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism--a multi-center trial].
Kaku Igaku. 1992 Apr;29(4):413-33.
9
[Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid].冠心病患者室性心律失常与心肌脂肪酸代谢的关系:使用碘-123β-甲基-对碘苯基十五烷酸的评估
J Cardiol. 1999 Aug;34(2):61-9.
10
Relationship between evaluation by quantitative fatty acid myocardial scintigraphy and response to beta-blockade therapy in patients with dilated cardiomyopathy.扩张型心肌病患者定量脂肪酸心肌闪烁显像评估与β受体阻滞剂治疗反应的关系
Eur J Nucl Med. 2001 Dec;28(12):1811-6. doi: 10.1007/s00259-001-0668-2. Epub 2001 Oct 18.

引用本文的文献

1
Is I-123-beta-methyl-p-iodophenyl-methylpentadecanoic acid imaging useful to evaluate asymptomatic patients with hypertrophic cardiomyopathy? I-123 BMIPP imaging to evaluate asymptomatic hypertrophic cardiomyopathy.I-123-β-甲基-对碘苯基-甲基十五烷酸成像对评估肥厚型心肌病无症状患者有用吗?I-123 BMIPP成像用于评估无症状肥厚型心肌病。
Int J Cardiovasc Imaging. 2003 Dec;19(6):499-510. doi: 10.1023/b:caim.0000004262.48898.5d.